Table 1 Comparison of clinicopathologic characteristics between LN-negative SRC and non-SRC GC patients.

From: Prognostic Impact of the Signet Ring Cell Type in Node-Negative Gastric Cancer

Variable

SRC

Non-SRC

P

No. of

Patients

(n = 90)

%

No. of

Patients

(n = 390)

%

Age, years

 Mean

57.1

57.7

0.646

 SD

10.6

11.7

Sex

 Male

64

71.1

285

73.1

0.696

 Female

26

28.9

105

26.9

Tumour location

 Upper stomach

20

22.2

131

33.6

0.141

 Middle stomach

28

31.1

103

26.4

 Lower stomach

28

31.1

116

29.7

 Overlapping

14

15.6

40

10.3

AJCC stage

 1

48

53.3

275

70.5

0.006

 2

29

32.2

85

21.8

 3

13

14.5

30

7.7

Tumour grade

 1

12

13.3

74

19.0

0.161

 2

19

21.1

103

26.4

 3

59

65.6

213

54.6

Tumour stage

 T1a

16

17.8

185

47.4

<0.001

 T1b

5

5.6

26

6.7

 T2

27

30.0

64

16.4

 T3

29

32.2

85

21.8

 T4

13

14.4

30

7.7

Perineural invasion

 Negative

42

46.7

226

57.9

0.060

 Positive

48

53.3

164

42.1

Vascular invasion

 Negative

77

85.6

348

89.2

0.358

 Positive

13

14.4

42

10.8

Number of retrieved LNs

 <15

9

10.0

21

5.4

0.143

 ≥15

81

90.0

369

94.6

Chemotherapy

 Yes

29

32.2

106

27.2

0.363

 No

61

67.8

284

72.8

  1. Abbreviations: SRC, Signet Ring Cell. SD, Standard Deviation. AJCC, American Joint Committee on Cancer, 7th Edition. LNs, Lymph Nodes.